- Home
- MBC vs GRDN Comparison
MBC vs GRDN Comparison
Compare MBC & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBC
- GRDN
- Stock Information
- Founded
- MBC 1954
- GRDN 2004
- Country
- MBC United States
- GRDN United States
- Employees
- MBC N/A
- GRDN N/A
- Industry
- MBC Agricultural Chemicals
- GRDN Retail-Drug Stores and Proprietary Stores
- Sector
- MBC Industrials
- GRDN Consumer Staples
- Exchange
- MBC Nasdaq
- GRDN Nasdaq
- Market Cap
- MBC 1.6B
- GRDN 1.7B
- IPO Year
- MBC N/A
- GRDN 2024
- Fundamental
- Price
- MBC $12.66
- GRDN $28.32
- Analyst Decision
- MBC Strong Buy
- GRDN Strong Buy
- Analyst Count
- MBC 1
- GRDN 2
- Target Price
- MBC $15.00
- GRDN $30.00
- AVG Volume (30 Days)
- MBC 1.2M
- GRDN 278.8K
- Earning Date
- MBC 11-04-2025
- GRDN 11-10-2025
- Dividend Yield
- MBC N/A
- GRDN N/A
- EPS Growth
- MBC N/A
- GRDN N/A
- EPS
- MBC 0.72
- GRDN N/A
- Revenue
- MBC $2,777,000,000.00
- GRDN $1,326,604,000.00
- Revenue This Year
- MBC $0.13
- GRDN $16.33
- Revenue Next Year
- MBC $3.29
- GRDN $2.10
- P/E Ratio
- MBC $17.76
- GRDN N/A
- Revenue Growth
- MBC 4.05
- GRDN 18.53
- 52 Week Low
- MBC $9.63
- GRDN $17.29
- 52 Week High
- MBC $20.67
- GRDN $30.39
- Technical
- Relative Strength Index (RSI)
- MBC 46.62
- GRDN 65.34
- Support Level
- MBC $12.62
- GRDN $28.35
- Resistance Level
- MBC $13.25
- GRDN $29.90
- Average True Range (ATR)
- MBC 0.42
- GRDN 1.04
- MACD
- MBC -0.02
- GRDN 0.40
- Stochastic Oscillator
- MBC 38.66
- GRDN 78.10
About MBC MasterBrand Inc.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.